Healthcare - Medical - Devices - NASDAQ - US
$ 0.7919
-8.01 %
$ 41.6 M
Market Cap
-0.29
P/E
CASH FLOW STATEMENT
-131 M
OPERATING CASH FLOW
83 M
INVESTING CASH FLOW
43.7 M
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Outset Medical, Inc.
| Net Income | -173 M |
| Depreciation & Amortization | 5.81 M |
| Capital Expenditures | -3.44 M |
| Stock-Based Compensation | 38.6 M |
| Change in Working Capital | -773 K |
| Others | -4.88 M |
| Free Cash Flow | -135 M |
Cash Flow
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | |
|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | ||||||
| Net Income | (172.8) | (163.0) | (131.9) | (121.5) | (68.3) | (49.8) |
| Depreciation & Amortization | 5.8 | 5.2 | 5.2 | 3.2 | 1.9 | 1.1 |
| Deferred Income Tax | 0 | 0 | 3.1 | 2.5 | (4.1) | 75 K |
| Stock Based Compensation | 38.6 | 27.2 | 17.4 | 21.4 | 0.9 | 0.8 |
| Other Operating Activities | (2.2) | 6.0 | 1.6 | 1.2 | 0.9 | 1.8 |
| Change in Working Capital | (0.8) | (21.1) | (25.6) | (5.8) | (1.6) | (0.2) |
| Cash From Operations | (131.4) | (145.7) | (130.3) | (99.0) | (70.3) | (46.4) |
| INVESTING CASH FLOW | ||||||
| Capital Expenditures | (3.4) | (8.3) | (3.1) | (9.1) | (3.3) | (1.8) |
| Other Items | 86.5 | (58.0) | (139.4) | 13.1 | 77.6 | (67.0) |
| Cash From Investing Activities | 83.0 | (66.3) | (142.5) | 3.9 | 74.3 | (68.8) |
| FINANCING CASH FLOW | ||||||
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Debt Repaid | 33.2 | 64.9 | 0 | (1.4) | 9 K | 9 K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 10.4 | 8.0 | 11.1 | 513.8 | 0.3 | 0.3 |
| Cash From Financing Activities | 43.7 | 72.9 | 160.1 | 385.7 | 0.2 | 134.9 |
| CHANGE IN CASH | ||||||
| Net Change In Cash | (4.7) | (139.1) | (112.6) | 290.6 | 4.3 | 19.7 |
| FREE CASH FLOW | ||||||
| Free Cash Flow | (134.8) | (154.1) | (133.4) | (108.1) | (73.6) | (48.2) |